ArticleFrontiers in immunology2025
A flexible systems analysis pipeline for elucidating spatial relationships in the tumor microenvironment linked with cellular phenotypes and patient-level features.
Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Scalable 3D cell-interaction analysis via supercell graphs for prostate cancer risk stratification.bioRxiv : the preprint server for biology · 2026Article
- Differences in T-cell Densities and Neighborhood Patterns in Human Colorectal Adenomas and Sessile Serrated Lesions.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2026Article
- Deciphering immunosuppressive niches by spatial single-cell proteomics: spatial interaction networks and translational opportunities.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Introduction: Quantitative investigation of how the spatial organization of cells within the tumor microenvironment associates with disease progression, patient outcomes, and that cell's phenotypic state remains a key challenge in cancer biology. High-dimensional multiplexed imaging offers an opportunity to explore these relationships at single-cell resolution. Methods: We developed a computational pipeline to quantify and analyze the neighborhood profiles of individual cells in multiplexed immunofluorescence images. The pipeline characterizes spatial co-localization patterns within the tumor microenvironment and applies interpretable supervised machine learning models, specifically orthogonal partial least squares analysis (OPLS), to identify spatial relationships predictive of cell states and clinical phenotypes. Results: We applied this framework to a previously published non-small cell lung cancer (NSCLC) cohort across four applications. At the cellular level, we identified neighborhood features associated with lymphocyte activation states. At the tumor-immune interface, we demonstrated that the immune cell composition surrounding major histocompatibility complex class I-expressing (MHC I Discussion: By integrating cell-segmented imaging data with interpretable modeling, our pipeline reveals key spatial determinants of tumor biology. These findings generate testable mechanistic hypotheses about intercellular interactions and support the development of spatially informed prognostic and therapeutic strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.